Advertisement
Screener

Twist Bioscience Corporation (TWST) Net Margin

Twist Bioscience Corp Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Twist Bioscience Corp net margin for the quarter ending 2026-06-30 was -29.61%, a 239.49% decline year-over-year.
  • Twist Bioscience Corp net margin for the quarter ending 2026-03-31 was -39.76%, a change of 2.62% year-over-year.
  • Twist Bioscience Corp net margin for the quarter ending 2025-12-31 was -29.42%, a change of 6.19% year-over-year.
  • Twist Bioscience Corp net margin for the quarter ending 2025-09-30 was -27.41%, a change of 13.50% year-over-year.
  • Twist Bioscience Corp net margin for fiscal 2025 was -20.63%, a change of 46.07% from fiscal 2024.
  • Twist Bioscience Corp net margin for fiscal 2024 was -66.69%, a change of 16.79% from fiscal 2023.
  • Twist Bioscience Corp net margin for fiscal 2023 was -83.48%, a change of 23.54% from fiscal 2022.
  • Twist Bioscience Corp net margin for fiscal 2022 was -107.02%, a change of 7.91% from fiscal 2021.
Available history
2017-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2026-06-30-29.61%-$35.05M$118.38M
2026-03-31-39.76%-$44.02M$110.72M
2025-12-31-29.42%-$30.51M$103.7M
2025-09-30-27.41%-$27.14M$99.01M
2025-06-3021.23%$20.39M$96.06M
2025-03-31-42.38%-$39.33M$92.79M
2024-12-31-35.61%-$31.59M$88.71M
2024-09-30-40.91%-$34.66M$84.71M
2024-06-30-105.04%-$85.57M$81.46M
2024-03-31-60.41%-$45.49M$75.3M
2023-12-31-60.15%-$43.01M$71.5M
2023-09-30-69.08%-$46.24M$66.95M
2023-06-30-90.05%-$57.4M$63.74M
2023-03-31-98.30%-$59.16M$60.18M
2022-12-31-77.10%-$41.82M$54.24M
2022-09-30-89.20%-$51.12M$57.31M
2022-06-30-107.85%-$60.52M$56.11M
2022-03-31-126.06%-$60.67M$48.13M
2021-12-31-108.44%-$45.56M$42.02M
2021-09-30-108.67%-$41.24M$37.95M
2021-06-30-114.33%-$40.04M$35.02M
2021-03-31-121.52%-$37.92M$31.2M
2020-12-31-116.83%-$32.9M$28.16M
2020-09-30-74.98%-$24.32M$32.43M
2020-06-30-133.01%-$28.21M$21.21M
2020-03-31-164.63%-$31.77M$19.3M
2019-12-31-324.16%-$55.64M$17.16M
2019-09-30-198.14%-$31.18M$15.74M
2019-06-30-205.26%-$27.92M$13.6M
2019-03-31-191.29%-$25.93M$13.56M
2018-12-31-197.00%-$22.64M$11.49M
2018-09-30-235.54%-$19.8M$8.41M
2018-06-30-269.44%-$17.62M$6.54M
2018-03-31-273.65%-$16.87M$6.17M
2017-12-31-392.70%-$16.94M$4.31M

Annual Net Margin

DateNet MarginNet incomeRevenue
2025-09-30-20.63%-$77.67M$376.57M
2024-09-30-66.69%-$208.73M$312.97M
2023-09-30-83.48%-$204.62M$245.11M
2022-09-30-107.02%-$217.86M$203.57M
2021-09-30-114.94%-$152.1M$132.33M
2020-09-30-155.31%-$139.93M$90.1M
2019-09-30-197.98%-$107.67M$54.39M
2018-09-30-280.16%-$71.24M$25.43M
2017-09-30-550.85%-$59.31M$10.77M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78